World's first Phase II Nipah virus vaccine trial launch

Published on December 16, 2025

The trial will assess the safety and immune response of the ChAdOx1 NipahB vaccine, developed by scientists from Oxford's Pandemic Sciences Institute (PSI), in a region where the virus causes recurrent outbreaks.
Continue reading on website
Other news

Oxford researchers pilot AI tool to support cancer care planning

December 15, 2025
Researchers at the University of Oxford have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.

International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue

December 16, 2025
A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.